- Home
- CCEL vs PEPG Comparison
CCEL vs PEPG Comparison
Compare CCEL & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- PEPG
- Stock Information
- Founded
- CCEL 1989
- PEPG 2018
- Country
- CCEL United States
- PEPG United States
- Employees
- CCEL N/A
- PEPG N/A
- Industry
- CCEL Managed Health Care
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- PEPG Health Care
- Exchange
- CCEL Nasdaq
- PEPG Nasdaq
- Market Cap
- CCEL 39.9M
- PEPG 45.5M
- IPO Year
- CCEL 1997
- PEPG 2022
- Fundamental
- Price
- CCEL $4.83
- PEPG $1.25
- Analyst Decision
- CCEL Strong Buy
- PEPG Buy
- Analyst Count
- CCEL 1
- PEPG 3
- Target Price
- CCEL $8.50
- PEPG $7.67
- AVG Volume (30 Days)
- CCEL 13.2K
- PEPG 340.5K
- Earning Date
- CCEL 07-22-2025
- PEPG 08-07-2025
- Dividend Yield
- CCEL 20.62%
- PEPG N/A
- EPS Growth
- CCEL N/A
- PEPG N/A
- EPS
- CCEL 0.01
- PEPG N/A
- Revenue
- CCEL $32,102,750.00
- PEPG N/A
- Revenue This Year
- CCEL $2.49
- PEPG N/A
- Revenue Next Year
- CCEL $0.95
- PEPG N/A
- P/E Ratio
- CCEL $301.41
- PEPG N/A
- Revenue Growth
- CCEL 2.33
- PEPG N/A
- 52 Week Low
- CCEL $4.75
- PEPG $0.88
- 52 Week High
- CCEL $9.43
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- CCEL 40.85
- PEPG 46.05
- Support Level
- CCEL $4.80
- PEPG $1.07
- Resistance Level
- CCEL $6.35
- PEPG $1.27
- Average True Range (ATR)
- CCEL 0.26
- PEPG 0.10
- MACD
- CCEL -0.03
- PEPG -0.00
- Stochastic Oscillator
- CCEL 2.08
- PEPG 45.45
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.